Phillips AN - Search Results

1

The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.

Smith CJ, Phillips AN, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G, Johnson MA, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group. Smith CJ, et al. Among authors: phillips an. J Infect Dis. 2005 Oct 15;192(8):1387-97. doi: 10.1086/466534. Epub 2005 Sep 14. J Infect Dis. 2005. PMID: 16170756

2

CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.

Sabin C, Pasi J, Phillips A, Elford J, Janossy G, Lee C. Sabin C, et al. Thromb Haemost. 1994 Aug;72(2):214-7. Thromb Haemost. 1994. PMID: 7831654

3

The progression of HIV disease in a haemophilic cohort followed for 12 years.

Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. Sabin C, et al. Br J Haematol. 1993 Feb;83(2):330-3. doi: 10.1111/j.1365-2141.1993.tb08290.x. Br J Haematol. 1993. PMID: 8384472

4

CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, Janossy G. Mocroft A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):158-62. doi: 10.1097/00042560-199702010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052725

5

Access to medical care one year prior to diagnosis in 100 HIV-positive women.

Madge S, Olaitan A, Mocroft A, Phillips A, Johnson M. Madge S, et al. Fam Pract. 1997 Jun;14(3):255-7. doi: 10.1093/fampra/14.3.255. Fam Pract. 1997. PMID: 9201502

6

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 Feb 25;13(3):367-73. doi: 10.1097/00002030-199902250-00009. AIDS. 1999. PMID: 10199227

7

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.

Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 May 28;13(8):951-6. doi: 10.1097/00002030-199905280-00011. AIDS. 1999. PMID: 10371176

8

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. Among authors: phillips an. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

9

Brief report: two-year outcome of a multidrug regimen in patients who did not respond to a protease inhibitor regimen.

Youle M, Tyrer M, Fisher M, Lampe F, Wilson D, Ransom D, Story A, Mocroft A, Loveday C, Johnson MA, Phillips AN. Youle M, et al. Among authors: phillips an. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):58-61. doi: 10.1097/00126334-200201010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 11782591 Clinical Trial.

10

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.

Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, D'Arminio Monforte A, Hermans P, Goebel FD, Blaxhult A, Kirk O, Phillips AN; EuroSIDA Study Group. Lundgren JD, et al. Among authors: phillips an. J Infect Dis. 2002 Jan 15;185(2):178-87. doi: 10.1086/338267. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807691 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters